Gilead Sciences is a fantastic company that's revolutionized the treatment of numerous diseases. But click here to read why ...

HHS Secretary Robert F. Kennedy Jr, is a well-known vaccine critic, but it is way past time for human health to be put on a ...

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

Key drivers in the dementia and movement disorder treatment market include a growing geriatric population and new public awareness strategies. The report features a detailed analysis of major vendors ...

Nigeria’s manufacturing sector is turning inward for survival as the impact of the naira devaluation and foreign exchange ...

Deepak Nitrite's shares fell by 2%, making it one of the top losers on the Nifty Midcap 150 index, despite a mixed financial performance.

China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on ...

As of December 31, 2024, HALEON has a total of 117.055 million shares outstanding which are held by 5124 shareholders. Haleon ...

GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million.

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

KNOWING where to invest your cash is difficult as there are thousands of companies to choose from. That’s why Holly Mead, a ...